Please login to the form below

Not currently logged in
Email:
Password:

lampalizumab

This page shows the latest lampalizumab news and features for those working in and with pharma, biotech and healthcare.

Trials of Roche's new blindness candidate now underway

Trials of Roche's new blindness candidate now underway

Trials of Roche's new blindness candidate now underway. Lampalizumab in phase III for age-related maculardegeneration. ... Roche has started enrolling patients into phase III trials of lampalizumab for dry age-related macular degeneration (AMD) - a major

Latest news

  • Roche moves eye drug lampalizumab into phase III Roche moves eye drug lampalizumab into phase III

    Roche moves eye drug lampalizumab into phase III. It could be the first treatment for geographic atrophy. ... Sandra Horning, head of global product development and chief medical officer at Roche, said: “ Lampalizumab has the potential to represent a

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics